Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human KLKB1 Antikörper:
anti-Mouse (Murine) KLKB1 Antikörper:
anti-Rat (Rattus) KLKB1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Dog (Canine) Polyclonal KLKB1 Primary Antibody für WB - ABIN2782312
Tang, Yu, Williams, Springman, Jeffery, Sprengeler, Estevez, Sampang, Shrader, Spencer, Young, McGrath, Katz: Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein. in The Journal of biological chemistry 2005
these data indicate that KLKB1 induces inflammatory reactions in human dental tissues via protease-activated receptor 1 (zeige F2R Antikörper)
von Willebrand factor (zeige VWF Antikörper) activity and concentration of prekallikrein may both be of importance regarding the evolution of thrombus in abdominal aortic aneurysm and possible biomarkers for aneurysm growth.
KLKB1 mRNA expression is a putative molecular biomarker in chronic lymphocytic leukemia.
Genotyping these subjects revealed that the carriers of the minor alleles at the two loci- F12 (zeige F12 Antikörper) and KLKB1 had a significant association with reduced levels of active plasma renin (zeige REN Antikörper).
2 genetic loci (kininogen 1 (zeige KNG1 Antikörper) and kallikrein (zeige KLK4 Antikörper) B) influencing key components of the RAAS, consistent with the close interrelation between the kallikrein (zeige KLK4 Antikörper)-kinin system and the RAAS.
PRCP1 interacts with plasma kallikrein (PK) at multiple sites for PK activation.
FXI (zeige F11 Antikörper) may have a role in risk of ischemic stroke, but not myocardial infarct; FXII (zeige F12 Antikörper) and prekallikrein may not have a role in either
plasma kallikrein and FXIa activate pro-HGF (zeige HGF Antikörper) in vitro
the effect of kininogen (zeige KNG1 Antikörper) degradation by human neutrophil elastase (HNE (zeige ELANE Antikörper)) on kinin generation by tissue and plasma kallikreins.
Crystallization and x-ray crystal structure determination have yielded the first three-dimensional views of the catalytic domain of plasma kallikrein
Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator (zeige PLAT Antikörper) therapy in mice after stroke.
we found that post-ejaculated semen from fertile wild-type males was solidified and the sperm were entrapped in Wnt7aCre/+;Esr1f/f uteri, compared to the watery semen (liquefied) found in Esr1f/f controls.Kallikrein-related peptidases 3 (KLK3 (zeige PSA Antikörper)) and other kallikrein (zeige KLK1 Antikörper)-related peptidases from male prostate glands are responsible for semen liquefaction by cleaving gel-forming proteins
Klkb1(-/-) mice have a novel mechanism for thrombosis protection in addition to reduced contact activation. This pathway arises when bradykinin delivery to vasculature is compromised and mediated by increased receptor Mas (zeige MAS1 Antikörper), prostacyclin, Sirt1 (zeige SIRT1 Antikörper), and KLF4 (zeige KLF4 Antikörper)
Plasma kallikrein deletion prevents occlusive thrombus formation in mice with a minimal role in provoked bleeding.
PKK (zeige RIPK4 Antikörper) or fXII (zeige F12 Antikörper) deficiency reduced thrombus formation in both arterial and venous thrombosis models, without an apparent effect on hemostasis.
Data suggest that LGG secreting PSA (zeige NPEPPS Antikörper) may activate antigen specific immune responses when instilled intravesically and IL15 (zeige IL15 Antikörper) could enhance this response.
the prekallikrein gene (Klkb1) is expressed highly in the mammary gland during stromal remodeling periods including puberty and postlactational involution.
Plasma prekallikrein is a glycoprotein that participates in the surface-dependent activation of blood coagulation, fibrinolysis, kinin generation and inflammation. It is synthesized in the liver and secreted into the blood as a single polypeptide chain. Plasma prekallikrein is converted to plasma kallikrein by factor XIIa by the cleavage of an internal Arg-Ile bond. Plasma kallikrein therefore is composed of a heavy chain and a light chain held together by a disulphide bond. The heavy chain originates from the amino-terminal end of the zymogen and contains 4 tandem repeats of 90 or 91 amino acids. Each repeat harbors a novel structure called the apple domain. The heavy chain is required for the surface-dependent pro-coagulant activity of plasma kallikrein. The light chain contains the active site or catalytic domain of the enzyme and is homologous to the trypsin family of serine proteases. Plasma prekallikrein deficiency causes a prolonged activated partial thromboplastin time in patients.
, plasma kallikrein
, plasma kallikrein heavy chain
, plasma kallikrein light chain
, plasma prekallikrein
, antigen, prostate specific
, fletcher factor
, kallikrein 3, plasma
, kallikrein B, plasma (Fletcher factor) 1
, Plasma kallikrein
, plasma kallikrein-like
, plasma kallikrein B1